SE9102079D0 - Purified ciliary neurotrophic factor - Google Patents

Purified ciliary neurotrophic factor

Info

Publication number
SE9102079D0
SE9102079D0 SE9102079A SE9102079A SE9102079D0 SE 9102079 D0 SE9102079 D0 SE 9102079D0 SE 9102079 A SE9102079 A SE 9102079A SE 9102079 A SE9102079 A SE 9102079A SE 9102079 D0 SE9102079 D0 SE 9102079D0
Authority
SE
Sweden
Prior art keywords
cntf
neurotrophic factor
ciliary neurotrophic
data
methods
Prior art date
Application number
SE9102079A
Other languages
English (en)
Other versions
SE513358C2 (sv
SE9102079L (sv
Inventor
Franklin D Collins
Leu-Fen Lin
Drzislav Mismer
Christine Ko
Original Assignee
Synergen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/293,851 external-priority patent/US5011914A/en
Priority claimed from US07/404,533 external-priority patent/US4997929A/en
Application filed by Synergen Inc filed Critical Synergen Inc
Publication of SE9102079D0 publication Critical patent/SE9102079D0/sv
Publication of SE9102079L publication Critical patent/SE9102079L/sv
Publication of SE513358C2 publication Critical patent/SE513358C2/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH] (Somatotropin)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
SE9102079A 1989-01-05 1991-07-03 Ciliär neurotropisk ischiasnervprotein faktor, dess framställning och använding i farmaceutisk komposition SE513358C2 (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US07/293,851 US5011914A (en) 1989-01-05 1989-01-05 Purified ciliary neurotrophic factor
US07/404,533 US4997929A (en) 1989-01-05 1989-09-08 Purified ciliary neurotrophic factor
US07/458,564 US5141856A (en) 1989-01-05 1989-12-28 Expression of purified ciliary neurotrophic factor
PCT/US1990/000022 WO1990007341A1 (en) 1989-01-05 1990-01-05 Purified ciliary neurotrophic factor

Publications (3)

Publication Number Publication Date
SE9102079D0 true SE9102079D0 (sv) 1991-07-03
SE9102079L SE9102079L (sv) 1991-07-03
SE513358C2 SE513358C2 (sv) 2000-08-28

Family

ID=27404236

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9102079A SE513358C2 (sv) 1989-01-05 1991-07-03 Ciliär neurotropisk ischiasnervprotein faktor, dess framställning och använding i farmaceutisk komposition

Country Status (21)

Country Link
US (2) US5141856A (sv)
EP (1) EP0385060B1 (sv)
JP (2) JPH0768270B2 (sv)
KR (1) KR930012105B1 (sv)
AU (1) AU7032496A (sv)
BR (1) BR9006996A (sv)
CH (1) CH681426A5 (sv)
DD (1) DD299318A5 (sv)
DE (1) DE4090006C2 (sv)
DK (1) DK131391A (sv)
ES (1) ES2091768T3 (sv)
FI (1) FI104375B (sv)
GB (1) GB2246132B (sv)
GR (1) GR3021705T3 (sv)
HU (2) HUT58792A (sv)
IE (1) IE81151B1 (sv)
IL (1) IL92958A (sv)
NL (1) NL9020024A (sv)
NZ (1) NZ231985A (sv)
SE (1) SE513358C2 (sv)
WO (1) WO1990007341A1 (sv)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5714585A (en) * 1987-10-26 1998-02-03 Sterling Winthrop, Inc. Antibodies that are immunoreactive with interleukin-7
US5328988A (en) * 1987-10-26 1994-07-12 Immunex Corporation Interleukin-7
US5141856A (en) * 1989-01-05 1992-08-25 Synergen, Inc. Expression of purified ciliary neurotrophic factor
IE903130A1 (en) 1989-09-15 1991-03-27 Regeneron Pharma Ciliary neurotrophic factor
NO911025L (no) * 1990-03-14 1991-09-16 Fidia Spa Fremgangsmaate til isolering og ekspresjon av human ciliarneuronotropisk faktor ved rekombinant dna-teknikk.
US6511823B1 (en) * 1990-08-20 2003-01-28 American Cyanamid Corporation Heparin binding neurotrophic factor gene sequence
IT1247150B (it) * 1991-01-21 1994-12-12 Fidia Spa Processo per la sintesi e la purificazione del fattore neuronotroficociliare umano (cntf) da escherichia coli.
US5593857A (en) * 1991-08-23 1997-01-14 Scios Inc. Production of homogeneous truncated CNTF
JPH07503128A (ja) * 1991-11-11 1995-04-06 フィディーア・ソシエタ・ペル・アチオニ ヒト毛様体ニューロン親和性因子の先端欠失型および突然変異タンパク質型の合成と精製
US5360740A (en) * 1992-07-02 1994-11-01 Regeneron Pharmaceuticals, Inc. Assay system for degenerative muscle disease
IL108464A0 (en) * 1993-01-29 1994-04-12 Regeneron Pharma Methods of treatment using ciliary neurotrophic factor
EP0632008B1 (en) * 1993-06-01 1998-02-04 Ono Pharmaceutical Co., Ltd. Pentanoic acid derivatives
AU1847695A (en) * 1994-02-22 1995-09-04 Syntex-Synergen Neuroscience Joint Venture, The Pharmaceutical formulations of cntf
WO1995029237A1 (en) * 1994-04-25 1995-11-02 Genentech, Inc. Cardiotrophin and uses therefor
US7258983B2 (en) * 1994-04-25 2007-08-21 Genentech, Inc. Cardiotrophin-1 compositions and methods for the treatment of tumor
US5534615A (en) * 1994-04-25 1996-07-09 Genentech, Inc. Cardiac hypertrophy factor and uses therefor
US6472585B1 (en) 1994-04-25 2002-10-29 Genentech, Inc. Cardiotrophin-1 defective mouse
US5739307A (en) * 1995-08-28 1998-04-14 Washington University Polynucleotide encoding neurturin neurotrophic factor
US6743628B1 (en) 1995-08-28 2004-06-01 Washington University Method of cell culture using neurturin
WO1997033911A1 (en) * 1996-03-14 1997-09-18 Washington University Persephin and related growth factors
US6222022B1 (en) 1996-03-14 2001-04-24 Washington University Persephin and related growth factors
US7015316B1 (en) * 1996-03-14 2006-03-21 Washington University Polynucleotides encoding human persephin and related growth factors
US6299895B1 (en) 1997-03-24 2001-10-09 Neurotech S.A. Device and method for treating ophthalmic diseases
IT1288388B1 (it) 1996-11-19 1998-09-22 Angeletti P Ist Richerche Bio Uso di sostanze che attivano il recettore del cntf ( fattore neurotrofico ciliare) per la preparazione di farmaci per la terapia
US6042579A (en) * 1997-04-30 2000-03-28 Medtronic, Inc. Techniques for treating neurodegenerative disorders by infusion of nerve growth factors into the brain
US6689573B1 (en) * 1999-05-24 2004-02-10 New England Biolabs, Inc. Method for screening restriction endonucleases
EP1296720A2 (en) 2000-04-14 2003-04-02 The Uab Research Foundation Poliovirus replicons encoding therapeutic agents and uses thereof
US20050064555A1 (en) * 2003-07-09 2005-03-24 Xencor, Inc. Ciliary neurotrophic factor variants
US20100143500A1 (en) * 2006-10-31 2010-06-10 The Ohio State University Research Foundation Methods and Compositions for Inhibiting GSK-3 In Glial Cell Related Disorders
WO2012075184A2 (en) 2010-12-02 2012-06-07 Neurotech Usa, Inc. Cell lines that secrete anti-angiogenic antibody-scaffolds and soluble receptors and uses thereof
ES2833457T3 (es) 2015-05-27 2021-06-15 Neurotech Usa Inc Uso de terapia con células encapsuladas para el tratamiento del glaucoma

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US458564A (en) * 1891-09-01 Ring-gage
US404533A (en) * 1889-06-04 Signments
US570651A (en) * 1896-11-03 Motor-driven fan
US429517A (en) * 1890-06-03 Packing-box
US408172A (en) * 1889-07-30 Steam-boiler house
US293851A (en) * 1884-02-19 de castro
US4399216A (en) * 1980-02-25 1983-08-16 The Trustees Of Columbia University Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
US4923696A (en) * 1987-05-04 1990-05-08 Baylor College Of Medicine Method to prepare a neurotrophic composition
US5028622A (en) * 1988-05-06 1991-07-02 Ajinomoto Company, Inc. Administration of amino acids as treatment for neurodegenerative disorders
US5011914A (en) * 1989-01-05 1991-04-30 Collins Franklin D Purified ciliary neurotrophic factor
US4997929A (en) * 1989-01-05 1991-03-05 Synergen, Inc. Purified ciliary neurotrophic factor
US5141856A (en) * 1989-01-05 1992-08-25 Synergen, Inc. Expression of purified ciliary neurotrophic factor
CA2047718A1 (en) * 1989-03-15 1990-09-16 Marston Manthorpe Purified ciliary neurotrophic factor
NO911867L (no) * 1989-09-15 1991-07-09 Max Planck Gesellsch Zur Foerd Ciliaer neurotrofisk faktor.
IE903130A1 (en) * 1989-09-15 1991-03-27 Regeneron Pharma Ciliary neurotrophic factor
US5349056A (en) * 1992-10-09 1994-09-20 Regeneron Pharmaceuticals Modified ciliary neurotrophic factors

Also Published As

Publication number Publication date
JPH04502916A (ja) 1992-05-28
HUT58792A (en) 1992-03-30
ES2091768T3 (es) 1996-11-16
BR9006996A (pt) 1991-11-12
IL92958A0 (en) 1990-09-17
GB2246132A8 (en) 2001-05-22
IL92958A (en) 1997-09-30
EP0385060A3 (en) 1991-04-03
WO1990007341A1 (en) 1990-07-12
KR930012105B1 (ko) 1993-12-24
IE81151B1 (en) 2000-05-03
DD299318A5 (de) 1992-04-09
IE900020L (en) 1990-07-05
DE4090006C2 (de) 1996-09-19
AU7032496A (en) 1997-01-16
CH681426A5 (sv) 1993-03-31
KR910700068A (ko) 1991-03-13
AU642858B2 (en) 1993-11-04
JPH0768270B2 (ja) 1995-07-26
DK131391D0 (da) 1991-07-05
NL9020024A (nl) 1991-10-01
EP0385060B1 (en) 1996-08-28
FI913251A0 (fi) 1991-07-04
SE513358C2 (sv) 2000-08-28
NZ231985A (en) 1992-12-23
AU4838190A (en) 1990-08-01
GB9113704D0 (en) 1991-08-21
GB2246132B (en) 1993-09-15
JPH1129598A (ja) 1999-02-02
SE9102079L (sv) 1991-07-03
EP0385060A2 (en) 1990-09-05
US5780600A (en) 1998-07-14
GR3021705T3 (en) 1997-02-28
FI104375B (sv) 2000-01-14
HU211933A9 (en) 1996-01-29
US5141856A (en) 1992-08-25
GB2246132A (en) 1992-01-22
DK131391A (da) 1991-09-05

Similar Documents

Publication Publication Date Title
SE9102079D0 (sv) Purified ciliary neurotrophic factor
US5349056A (en) Modified ciliary neurotrophic factors
UA39161C2 (uk) Рекомбінантний білок gm-csf для збільшення продукції гранулоцитів і макрофагів у пацієнтів, вектор і кднк, що його кодують
BE902119A (fr) Polypeptide physiologiquement actif humain, acide desoxyribonucleique comprenant une sequence de base codant ce polypeptide, procede de production de ce polypeptide, et composition pharmaceutique le contenant.
ATE107362T1 (de) Polypeptid-mutanten des menschlichen tnf und für diese mutanten codierende dns.
DE68910354T2 (de) Menschliches mutantes Angiogenin (Angiogenese-Faktor mit überlegener Angiogenin-Aktivität), Gene dafür und Methode zur Expression.
DE69533627D1 (en) Humanes chemokin beta-13
IL75963A (en) Omega interferon polypeptides of type 1,n-glycosylated derivatives thereof with omega interferon activity,polynucleotide sequences encoding the omega interferon polypeptides,methods for the preparation of the polypeptides and pharmaceutical compositions containing them
BG60238B1 (bg) Човешки тумор- некротизиращ фактор
PT86276A (en) Method for the production of hybrid proteins
ATE153069T1 (de) Vektoren und zusammensetzungen zur expression von glykosilationsmutanten des menschlichen proteins- c
GR3015689T3 (en) Process for the construction of an animal cell line for the production of human beta-interferon.
DK587488D0 (da) Fibroblast-vaekstfaktor, nucleotidsekvens kodende derfor, praeparat indeholdende faktoren og fremgangsmaade til fremstilling deraf
AUPN154295A0 (en) Nucleic acid molecule encoding a protein with avian gamma-interferon activity
EP0317627A4 (en) Oncogene-encoded polypeptide having growth factor activity and methods of production and use thereof
CA2032167A1 (en) Dna coding for protein binds to enhancer of.alpha.-fetoprotein gene
CA2047718A1 (en) Purified ciliary neurotrophic factor
DK595187D0 (da) Minactivin og fremgangsmaade til fremstilling deraf
ATE300554T1 (de) Bindegewebe-wachstumsfaktor 3.
ATE145939T1 (de) Mitogen für die glatte muskulatur und dessen kodierende dns
DE68913802T2 (de) Thymosin und TNF-kodierende DNA.
CA2006813A1 (en) Purified ciliary neurotrophic factor
MX9709090A (es) Quimiocina beta-11 humana y quimiocina alfa-1 humana.

Legal Events

Date Code Title Description
NUG Patent has lapsed